0717.jpg

Motohisa Suzuki, M.D.

Radiation Oncologist
Associate Specialist, Southern TOHOKU Proton Beam Therapy Center

  • Present Title & Affiliation

    • Associate Specialist, Southern TOHOKU Proton Beam, Therapy Center
  • Education

    • 2001 M.D.

      Yamagata University Faculty of Medicine, Japan

  • Certifications

    • 2012

      Board-certified Radiologist by Japan Radiological Society (JRS)

    • Board-certified Radiation Oncologist by Japanese Society for Radiation Oncology (JASTRO)
    • 2016

      Board-certified Radiology instructor for Redidents by Ministry of Health, Welfare and Labour, Japan

  • Professional Experience

    • 2004-2006

      Resident, Yamagata University Hospital, Japan

    • 2006-2008

      Clinical Fellow, Dept. of Radiology, Yamagata University Hospital, Japan

    • 2007-2008

      Physician, Dept. of Radiology, Yamagata Prefectural Shinjo Hospital, Japan

    • 2008

      Clinical Fellow, Dept. of Radiation Therapy, Yamagata University Hospital, Japan

    • 2008-2012

      Specailly-appointed Lecturer, Dept. of Radiology, Division of Radiation Oncology, Yamagata University Faculty of Medicine, Japan

    • 2012-present

      Associate Specialist, Southern TOHOKU Proton Beam Therapy Center, Japan

  • Skill Highlights

    • Radiation therapy for malignant (cancerous) tumors
  • Professional Memberships

    • Japan Radiological Society (JRS)
    • 2007

      Jpanese Society for Radiation Oncology (JASTRO)

  • Selected Publications

    • Kanako Takayama, Takahiro Kato, Tatsuya Nakamura, Yusuke Azami, Takashi Ono, Motohisa Suzuki, Akinori Takada, Hisashi Yamaguchi, Ichiro Seto, Tatsuhiko Nakasato, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Mitsudo, Nobukazu Fuwa, Masao Murakami, Proton Beam Therapy Combined With Intra-Arterial Infusion Chemotherapy for Stage IV Adenoid Cystic Carcinoma of the Base of the Tongue, Cancers (Basel) 2019 Sep 22;11(10):1413.

    • Takashi Ono, Tatsuya Nakamura, Yusuke Azami, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Masao Murakami, Kenji Nemoto, Proton beam therapy is a safe and feas ible treatmentfor patients with second primary lung cancer after lungresection, Thoracic Cancer 10 (2019) 289–295
    • Takashi Ono, Tatsuya Nakamura, Yusuke Azami, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Masao Murakami, Kenji Nemoto, Proton beam therapy is a safe and feas ible treatmentfor patients with second primary lung cancer after lungresection, Thoracic Cancer 10 (2019) 289–295
    • Takashi Ono, Tatsuya Nakamura, Yusuke Azami, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Masao Murakami, Kenji Nemoto, Proton beam therapy is a safe and feas ible treatmentfor patients with second primary lung cancer after lungresection, Thoracic Cancer 10 (2019) 289–295
    • Takashi Ono, Tatsuya Nakamura, Hisashi Yamaguchi, Yusuke Azami, Kanako Takayama, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Masao Murakami, Kenji Nemoto, Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer, Radiat Oncol. 2018; 13: 19. Published online 2018 Feb 5. doi: 10.1186/s13014-018-0967-4
    • Kimura, K, Nakamura, T., Ono, T., Azami Y., Suzuki, M., Wada, H., Takayama, K., Endo, H., Takeyama, T., Hirose, K., takai, Y., Kikuchi, Y., Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm, Hepatology Research, 14 February 2017 https://doi.org/10.1111/hepr.12874
    • Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto, High dose hypo-fractionated proton beam therapy is a safe and feasible treatment for central lung cancer, Radiology and Oncology | Volume 51: Issue 3, DOI: https://doi.org/10.1515/raon-2017-0023 Published online: 16 Jun 2017
    • Yojiro Ishikawa, Tatsuya Nakamura, Takahiro Kato, Noriyuki Kadoya, Motohisa Suzuki, Yusuke Azami, Masato Hareyama, Yasuhiro Kikuchi, Keiichi Jingu Dosemetric Parameters Predictive of Rib Fractures after Proton Beam Therapy for Early-Stage Lung Cancer, The Tohoku Journal of Experimental Medicine, 2016 Volume 238 Issue 4 Pages 339-345
    • Takayama K, Nakamura T, Takada A, Makita C, Suzuki M, Azami Y, Kato T, Hayashi Y, Ono T, Toyomasu Y, Hareyama M, Kikuchi Y, Daimon T, Mitsudo K, Tohnai I, Fuwa N., Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer. J Cancer Res Clin Oncol. 2016 Mar;142(3):659-67. 2015 Oct 31.

Printer Friendly